Equites Radar

HNGE · Hinge Health, Inc.

Health Information ServicesUnited StatesAnalyst view: Buy

$111.52

+1.45% last session

End-of-day data · close of 2026-10-23

Bullish5 bullish · 0 bearish technical signals
Consensus: Buy (1.53 from 16 analysts)
To mean target: +1.7%

Market cap

$9B

Enterprise value

$9B

Trailing P/E

36.8

Forward P/E

36.5

Dividend yield

0.0%

Beta

—

Avg volume

2M

Employees

1K

Daily Change %

1.45%

5 Days Change

10.86%

10 Days Change

4.56%

30 Days Change

19.13%

60 Days Change

22.17%

Month to Day Change

12.24%

Year to Day Change

136.66%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.53
Covering analysts16
Mean price target$113.38
Low price target$90.00
Upside to mean target+1.7%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)68.7
50-day MA$95.50
200-day MA$65.38
Price vs 50-day MA+16.8%
Price vs 200-day MA+70.6%
MACD histogram0.76
Volume vs 3-month avg0.8×
52w low $31.1752w high $112.00

Analyst sentiment over time — HNGE

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-10-16

Latest call per bank · past 12 months

Barclays

Overweight

$110

-1.4% vs price
▲ raised from $100Maintains · 2026-10-12

RBC Capital

Outperform

$110

-1.4% vs price
▲ raised from $75.00Maintains · 2026-08-05

Wells Fargo

Overweight

$103

-7.6% vs price
▲ raised from $90.00Maintains · 2026-08-05

Morgan Stanley

Overweight

$108

-3.2% vs price
▲ raised from $72.00Maintains · 2026-07-13

Recent rating actions

DateFirmActionRatingPrice target
2026-10-16KeybancMaintainsOverweight$125 → $140
2026-10-12BarclaysMaintainsOverweight$100 → $110
2026-09-30NeedhamMaintainsBuy$97.00 → $115
2026-09-22BairdMaintainsNeutral$85.00 → $90.00
2026-09-08StifelMaintainsBuy$96.00 → $115
2026-08-11Truist SecuritiesMaintainsBuy$85.00 → $112
2026-08-05RBC CapitalMaintainsOutperform$75.00 → $110
2026-08-05CitizensMaintainsMarket Outperform$96.00 → $107

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-10-23

  • neutral: RSI (14): RSI is 69 — neutral momentum, neither overbought nor oversold.
  • bullish: Price vs 50-day MA: Trading 16.8% above the 50-day MA ($95.50).
  • bullish: Price vs 200-day MA: Trading 70.6% above the 200-day MA ($65.38).
  • bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • bullish: MACD (12,26,9): MACD histogram is positive (+0.76) — short-term momentum is improving.
  • bullish: 52-week range: Price is within 5% of the 52-week high ($112.00).

HNGE Price Chart

Loading chart for HNGE…

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$4.29
Net Debt / EBITDA-4.0
WACC0.0%
Revenue growth53.00%
Earnings growth—

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

More in Health Information Services

Screen HNGE against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.